TuHURA Biosciences, Inc.
HURA · NASDAQ
9/30/2025 | 6/30/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $110,497 | $99,358 | $173,104 | $14,881 |
| - Cash | $0 | $8,513 | $12,657 | $3,020 |
| + Debt | $0 | $559 | $203 | $0 |
| Enterprise Value | $110,497 | $91,404 | $160,650 | $11,861 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$18 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$9,524 | -$5,455 | -$2,180 |
| % Margin | – | – | – | – |
| Net Income | -$23,297 | -$9,524 | -$5,996 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | -0.214 | -0.142 | -3 |
| % Growth | 100% | -50.9% | 95.3% | – |
| Operating Cash Flow | – | -$10,987 | -$2,600 | -$1,889 |
| Capital Expenditures | – | -$48 | -$21 | $0 |
| Free Cash Flow | – | -$11,035 | -$2,621 | -$1,889 |